A new stem cell therapy clinical trial published in The Journals of Gerontology could change the process of aging and give patients the ability to live longer with stronger bodies.
Stem cell research seems to be working its way into so many facets of medical treatment lately that many people are wondering if there is anything the regenerative cells can’t do. We’ve seen miraculous discoveries about the power of stem cells on neurological conditions like MS and Parkinson’s disease and complications from chronic diseases like diabetes and COPD. Stem cell therapies are also treating orthopedic conditions like osteoarthritis and autoimmune disorders like rheumatoid arthritis. Stem cell power is even being used in cosmetic procedures like hair loss treatments and skincare. Historically, many people have been apprehensive about exploring the possibilities of stem cell therapy because of perceived ethical barriers, but with new extraction procedures and donor options, stem cell therapy is quickly changing skeptics to believers one study at a time.
Often times, stem cell therapy is only associated with stem cells from embryos but mesenchymal or “adult” stem cells derived from tissue are also a viable and powerful source of stem cell power. In addition to being a great approach to other age-induced degenerating the disease, mesenchymal stem cells are the champion of new research addressing the progression of frailty in senior citizens.
“Researchers discovered the test subjects were experiencing a significant reduction in inflammation, increased strength and an improved level of energy. “
In Phase Two of the trials, a control group was introduced for a double-blind study and the outcome was consistent with the first phase with no side effects reported. Phase Two subjects’ improved aging fragility symptoms left researchers astonished. Medical advancements have extended life a great deal, so as we demand more from our bodies, positive results from studies like this using minimally invasive, solitary treatments are making the prospect of longer life more promising.
Phase Two of these trials is being extended to cover more patients across a wider geographic area to prove safety and efficacy and also to move closer to final FDA approval of the first aging fragility treatment.
The expansion of stem cell research and the use of stem cell therapies in medicine is offering the promise of a better tomorrow for many of us as longevity becomes more a reality than a hope. Stem cells have proved beneficial in so many areas of the body. This aging fragility study will most likely be the first of many age-related stem cell trials we see in the near future, and it certainly won’t be the last we see with such amazingly promising results.
Learn More About Stem Cell Therapy
Regenerative Medicine Has the Potential to Treat Stroke Victoms
A large percentage of Americans are in the dark when it comes to
understanding and reacting to the symptoms of an actively occurring stroke.